Kaitocephalin

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameKaitocephalin

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGlutamate receptor ionotropic AMPA antagonistsGlutamate [NMDA] receptor antagonists

TargetsGlutamate [NMDA] receptorGlutamate receptor ionotropic AMPA

Therapy Area/IndicationsBrain Ischemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive Companies +[1] N/A

Active IndicationsN/A

Inactive IndicationsBrain Ischemia

ATC CodeN/A